In a development that has drawn wide attention in medicine research, viruses that kill bacteria are being revived as therapy. It is the kind of result that blurs the line between a scholarly finding and mainstream news — rigorous in substance, yet consequential enough to matter far beyond the lab.
What happened
They offer hope against antibiotic-resistant infections.
Behind the result
Case reports describe dramatic individual rescues.
The significance
Phages target specific bacteria with precision.
Caveats
Clinical trials aim to formalize the approach.
In short
Clinical trials aim to formalize the approach.
The wider view
Researchers caution that findings like this evolve as work is replicated and extended, but the trajectory is clear: medicine is moving fast, and phage therapy’s comeback against superbugs marks a notable step.
